| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Pitavastatin |
| Brand | Livazo® |
| Indication | Is indicated for the reduction of elevated TC and LDL-C, in adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia and combined (mixed) dyslipidaemia, when response to diet and other non-pharmacological measures are inadequate. |
| Assessment Process | |
| Rapid review commissioned | 22/12/2010 |
| Rapid review completed | 24/12/2010 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
